Found: 21
Select item for more details and to access through your institution.
The competitive athlete with type 1 diabetes.
- Published in:
- Diabetologia, 2020, v. 63, n. 8, p. 1475, doi. 10.1007/s00125-020-05183-8
- By:
- Publication type:
- Article
Treatment of HNF1-alpha MODY with the DPP-4 inhibitor Sitagliptin.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon‐like peptide‐1 receptor agonists.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1398, doi. 10.1111/dom.14701
- By:
- Publication type:
- Article
Glucose metabolism and thermogenesis during glucose and insulin infusion in severely underweight patients.
- Published in:
- 1992
- By:
- Publication type:
- journal article
803-P: The Association between Empagliflozin and Changes in Alanine Aminotransferase Levels: Data from the Association of British Clinical Diabetologists (ABCD) Audit Programme.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-803-P
- By:
- Publication type:
- Article
686-P: The Association of British Clinical Diabetologists (ABCD) United Kingdom Nationwide Semaglutide Audit.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-686-P
- By:
- Publication type:
- Article
2224-PUB: The Effect of Diabetes Duration on Response to Empagliflozin: Data from the Association of British Clinical Diabetologists (ABCD) Audit Programme.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2224-PUB
- By:
- Publication type:
- Article
1113-P: The Use of Empagliflozin and Dulaglutide Improves Metabolic and Glycemia Outcomes in a Real-World Primary Care Setting.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1113-P
- By:
- Publication type:
- Article
1110-P: Effect of Raised Alanine Transaminase (ALT) Levels on HbA1c in the Association of British Clinical Diabetologists (ABCD) Nationwide Audits of SGLT2 Inhibitors (SGLT2i).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1110-P
- By:
- Publication type:
- Article
1105-P: The Effect of Canagliflozin on Alanine Aminotransferase (ALT) Levels: Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Audit Programme.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1105-P
- By:
- Publication type:
- Article
1104-P: Many Benefits of Empagliflozin Persist in Those with Reduced Renal Function: Updated Data from the Association of British Clinical Diabetologists (ABCD) Audit Programme.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1104-P
- By:
- Publication type:
- Article
1209-P: Relationship between Canagliflozin Treatment Response and Duration of Diabetes: The Association of British Clinical Diabetologists (ABCD) Nationwide Canagliflozin Audit.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1209-P
- By:
- Publication type:
- Article
1201-P: Characteristics and Treatment Outcomes of Patients Treated with Empagliflozin in the ABCD Nationwide Empagliflozin Audit.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1201-P
- By:
- Publication type:
- Article
1200-P: Predictors of Glycaemic and Weight Response to Empagliflozin Treatment: The ABCD Nationwide Empagliflozin Audit.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1200-P
- By:
- Publication type:
- Article
2339-PUB: Effect of IDegLira on HbA1c and Weight: Data from the Association of British Clinical Diabetologists (ABCD) IDegLira Audit.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2339-PUB
- By:
- Publication type:
- Article
Cycling for people with type 1 diabetes.
- Published in:
- Practical Diabetes, 2013, v. 30, n. 7, p. 273, doi. 10.1002/pdi.1791
- By:
- Publication type:
- Article
Identifying hepatic nuclear factor 1alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetes.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Identifying Hepatic Nuclear Factor 1α Mutation in Children and Young Adults With a Clinical Diagnosis of Type 1 Diabetes.
- Published in:
- Diabetes Care, 2003, v. 26, n. 2, p. 333, doi. 10.2337/diacare.26.2.333
- By:
- Publication type:
- Article
2-Year Prospective Audit of the Effect of the Introduction of Insulin Lispro in Patients With Specific Clinical Indications.
- Published in:
- Diabetes Care, 1999, v. 22, n. 7, p. 1226, doi. 10.2337/diacare.22.7.1226
- By:
- Publication type:
- Article
Treatment of Malignant Otitis Externa in a Younger Diabetes Patient.
- Published in:
- Diabetes Care, 1992, v. 15, n. 11, p. 1826
- By:
- Publication type:
- Article
Prospective audit of the introduction of insulin glargine (lantus) into clinical practice in type 1 diabetic patients.
- Published in:
- 2003
- By:
- Publication type:
- letter